(Hill M AND Brotchie) OR (Hill M AND Bezard) - Search Results

Year	Number of Results
1995	2
1998	1
1999	3
2000	3
2001	2
2002	1
2003	2
2004	5
2005	1
2006	2
2007	2
2008	1
2009	1
2010	1
2013	3
2017	1
2018	3
2019	2
2020	2
2021	1
2022	0

1

NYX-458 Improves Cognitive Performance in a Primate Parkinson's Disease Model.

Barth AL, Schneider JS, Johnston TH, Hill MP, Brotchie JM, Moskal JR, Cearley CN. Barth AL, et al. Among authors: hill mp. Mov Disord. 2020 Apr;35(4):640-649. doi: 10.1002/mds.27962. Epub 2020 Jan 22. Mov Disord. 2020. PMID: 31967361

2

Pridopidine, a clinic-ready compound, reduces 3,4-dihydroxyphenylalanine-induced dyskinesia in Parkinsonian macaques.

Johnston TH, Geva M, Steiner L, Orbach A, Papapetropoulos S, Savola JM, Reynolds IJ, Ravenscroft P, Hill M, Fox SH, Brotchie JM, Laufer R, Hayden MR. Johnston TH, et al. Among authors: hill m. Mov Disord. 2019 May;34(5):708-716. doi: 10.1002/mds.27565. Epub 2018 Dec 21. Mov Disord. 2019. PMID: 30575996

3

Pharmacokinetic/Pharmacodynamic Correlation Analysis of Amantadine for Levodopa-Induced Dyskinesia.

Brigham EF, Johnston TH, Brown C, Holt JDS, Fox SH, Hill MP, Howson PA, Brotchie JM, Nguyen JT. Brigham EF, et al. Among authors: hill mp. J Pharmacol Exp Ther. 2018 Nov;367(2):373-381. doi: 10.1124/jpet.118.247650. Epub 2018 Aug 7. J Pharmacol Exp Ther. 2018. PMID: 30087157

4

A novel dopamine D3R agonist SK609 with norepinephrine transporter inhibition promotes improvement in cognitive task performance in rodent and non-human primate models of Parkinson's disease.

Schneider JS, Marshall CA, Keibel L, Snyder NW, Hill MP, Brotchie JM, Johnston TH, Waterhouse BD, Kortagere S. Schneider JS, et al. Among authors: hill mp. Exp Neurol. 2021 Jan;335:113514. doi: 10.1016/j.expneurol.2020.113514. Epub 2020 Oct 22. Exp Neurol. 2021. PMID: 33141071 Free PMC article.

5

DPI-289, a novel mixed delta opioid agonist / mu opioid antagonist (DAMA), has L-DOPA-sparing potential in Parkinson's disease.

Johnston TH, Versi E, Howson PA, Ravenscroft P, Fox SH, Hill MP, Reidenberg BE, Corey R, Brotchie JM. Johnston TH, et al. Among authors: hill mp. Neuropharmacology. 2018 Mar 15;131:116-127. doi: 10.1016/j.neuropharm.2017.11.046. Epub 2017 Nov 29. Neuropharmacology. 2018. PMID: 29197517

6

Rotigotine polyoxazoline conjugate SER-214 provides robust and sustained antiparkinsonian benefit.

Eskow Jaunarajs KL, Standaert DG, Viegas TX, Bentley MD, Fang Z, Dizman B, Yoon K, Weimer R, Ravenscroft P, Johnston TH, Hill MP, Brotchie JM, Moreadith RW. Eskow Jaunarajs KL, et al. Among authors: hill mp. Mov Disord. 2013 Oct;28(12):1675-82. doi: 10.1002/mds.25625. Epub 2013 Sep 3. Mov Disord. 2013. PMID: 24014074 Free article.

7

Neuroprotective strategies for Parkinson's disease: conceptual limits of animal models and clinical trials.

Meissner W, Hill MP, Tison F, Gross CE, Bezard E. Meissner W, et al. Among authors: hill mp. Trends Pharmacol Sci. 2004 May;25(5):249-53. doi: 10.1016/j.tips.2004.03.003. Trends Pharmacol Sci. 2004. PMID: 15120490 Review.

8

Use of catechol-O-methyltransferase inhibition to minimize L-3,4-dihydroxyphenylalanine-induced dyskinesia in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque.

Huot P, Johnston TH, Snoeren T, Koprich JB, Hill MP, Fox SH, Brotchie JM. Huot P, et al. Among authors: hill mp. Eur J Neurosci. 2013 Mar;37(5):831-8. doi: 10.1111/ejn.12093. Epub 2013 Jan 3. Eur J Neurosci. 2013. PMID: 23281915

9

TC-8831, a nicotinic acetylcholine receptor agonist, reduces L-DOPA-induced dyskinesia in the MPTP macaque.

Johnston TH, Huot P, Fox SH, Koprich JB, Szeliga KT, James JW, Graef JD, Letchworth SR, Jordan KG, Hill MP, Brotchie JM. Johnston TH, et al. Among authors: hill mp. Neuropharmacology. 2013 Oct;73:337-47. doi: 10.1016/j.neuropharm.2013.06.005. Epub 2013 Jun 14. Neuropharmacology. 2013. PMID: 23770260

10

Levetiracetam potentiates the antidyskinetic action of amantadine in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned primate model of Parkinson's disease.

Hill MP, Ravenscroft P, Bezard E, Crossman AR, Brotchie JM, Michel A, Grimée R, Klitgaard H. Hill MP, et al. J Pharmacol Exp Ther. 2004 Jul;310(1):386-94. doi: 10.1124/jpet.104.066191. Epub 2004 Mar 5. J Pharmacol Exp Ther. 2004. PMID: 15004218

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results